{
    "clinical_study": {
        "@rank": "110849", 
        "arm_group": [
            {
                "arm_group_label": "combination therapy of H2RA and surgicel", 
                "arm_group_type": "Experimental", 
                "description": "H2RA and surgicel"
            }, 
            {
                "arm_group_label": "Monotherapy of PPI", 
                "arm_group_type": "Experimental", 
                "description": "PPI"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to assess the effect of Surgicel\u00ae Fibrillar as adjuvant treatment\n      to  H2RA on preventing ulcer bleeding after ESD for gastric epithelial tumors"
        }, 
        "brief_title": "Surgicel\u00ae Fibrillar for Delayed Bleeding After ESD", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Benign Neoplasm of Stomach", 
            "Malignant Neoplasm of Stomach"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Hemorrhage", 
                "Stomach Neoplasms", 
                "Brain Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "1. Patient (1) Inclusion: Diagnosed as gastric dysplasia or early gastric cancer\n\n             -  Scheduled for ESD (2) Exclusion: Coagulopathy- liver cirrhosis, thrombocytopenia\n\n             -  Anti-platelet agents\n\n        2. Method\n\n      (1) Study group: combination with Surgicel\u00ae Fibrillar and H2RA (2) Control group:\n      monotherapy with PPI 3. Sample size : 157 4. Result\n\n        1. Primary endpoint: rate of delayed bleeding after ESD\n\n        2. Secondary endpoint: follow-up hemoglobin after ESD"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  ESD for gastric dysplasia or early gastric cancer\n\n        Exclusion Criteria:\n\n          -  Coagulopathy: liver cirrhosis, thrombocytopenia\n\n          -  Anti-platelet agents"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "146", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 27, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01758965", 
            "org_study_id": "MD_SCHBC_IRB_2012-06"
        }, 
        "intervention": [
            {
                "arm_group_label": "Monotherapy of PPI", 
                "description": "monotherapy of PPI", 
                "intervention_name": "PPI", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "combination therapy of H2RA and surgicel", 
                "description": "combination therapy of H2RA and surgicel", 
                "intervention_name": "H2RA and surgicel", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 12, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bucheon", 
                    "country": "Korea, Republic of", 
                    "state": "Gyeonggi-do", 
                    "zip": "420-767"
                }, 
                "name": "Digestive Disease Center, Department of Internal Medicine, Soonchunhyang University College of Medicine"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Surgicel\u00ae (Fibrillar) for Preventing Delayed Bleeding After ESD in Stomach: A Prospective Randomized Study", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Delayed bleeding rate after ESD", 
            "safety_issue": "Yes", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01758965"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Soonchunhyang University Hospital", 
            "investigator_full_name": "Su Jin Hong", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Soonchunhyang University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Soonchunhyang University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}